Skip to content

Dr. Sneha Swaroop,

Information about Dr. Sneha Swaroop at the University of Bradford.

School of Pharmacy & Medical Sciences
(Faculty of Life Sciences)
Photo of Dr. Sneha Swaroop


Dr Sneha Swaroop is a Lecturer in Cell and Molecular Biology at the School of Pharmacy and Medical Sciences. Her research focuses on stem cells in cancer, with the goal of identifying novel ways to target them and develop effective therapies for cancer patients. After earning her Master’s degree in Biotechnology, Dr Swaroop pursued a Ph.D. in the field of Oncology from the renowned Cancer Institute (WIA), India, where she extensively researched the role of the hedgehog pathway in maintaining cancer stem cells in serous adenocarcinoma of the ovary. As a testament to her excellent research capabilities, Dr Swaroop was awarded the prestigious Schlumberger Faculty for the Future (FFTF) Fellowship, allowing her to undertake post- doctoral research in drug discovery at the Institute of Cancer Therapeutics (ICT), University of Bradford. In this role, she evaluated novel cancer stem cell-targeted chemical probes and drug candidates in breast and prostate cancer, which has the potential to transform cancer treatment. Aside from her research, Dr Swaroop is also a dedicated STEM ambassador and educator, mentoring and training the next generation of scientists. She is also committed to engaging with wider community, participating in public engagement activities increasing awareness and understanding of cancer research.


Dr Sneha Swaroop’s research interests are centered around understanding the intricate biology of cancer stem cells and identifying novel ways to target them. Her research includes several noteworthy studies such as: 1) Characterising ovarian cancer stem cells (CSCs) using spheroid culture and evaluating the significance of embryonic signaling pathways.2) Identifying novel biomarkers for ovarian cancer stem cells using in silico approaches, establishing in vitro and in vivo models to study CSCs and evaluating novel therapeutic targets for improved treatment. 3) Evaluation of the effect of a dual PI3K δ/γ inhibitors on cancer stem cell proliferation in serous ovarian carcinoma. 4) Investigating stem cell gene expression in spheroids and deciphering splice variants of stem cell specific genes in teratoma and human embryonic stem cells followed by their analysis in two and three dimensional culture. 5) Establishing the role of CSCs in tumour angiogenesis and lymph angiogenesis in ovarian cancer.Moving forward, Dr Swaroop aims to continue exploring the biology of cancer stem cells in relation to the tumour microenvironment with the ultimate aim of developing more effective treatments for cancer patients. Currently Dr Swaroop is seeking motivated and passionate PhD students and Post Docs to explore the intricate self regulatory mechanisms of CSCs in ovarian cancer. Fellowship applications such as Schlumberger, Newton and Commonwealth from ideal candidates will be supported for conducting research in the filed of CSCs at the Institute of Cancer Therapeutics, Bradford. Please contact for more details.


There are 15 publications involving or that are attributed to Dr. Sneha Swaroop.

Peer Reviewed Journal

Dr. Sneha Swaroop has 15 publication(s) listed under peer reviewed journal.
Title Year Publication name Journal Volume Pages Authors Editors ISSN Publisher DOI Location
Therapeutic antibodies against cancer stem cells: a promising approach. 2017 Cancer Immunology, Immunotherapy 66 Sneha S;Nagare RP;Priya SK;Sidhanth C;Pors K;Ganesan TS; 1432-0851 10.1007/s00262-017-2049-0
Cancer stem cells contribute to angiogenesis and lymphangiogenesis in serous adenocarcinoma of the ovary. 2019 Angiogenesis 22 Krishnapriya S;Sidhanth C;Manasa P;Sneha S;Bindhya S;Nagare RP;Ramachandran B;Vishwanathan P;Murhekar K;Shirley S;Ganesan TS; 1573-7209 10.1007/s10456-019-09669-x
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin. 2017 Scientific Reports 7 Garg M;Kanojia D;Mayakonda A;Ganesan TS;Sadhanandhan B;Suresh S;S S;Nagare RP;Said JW;Doan NB;Ding LW;Baloglu E;Shacham S;Kauffman M;Koeffler HP; 2045-2322 10.1038/s41598-017-10325-x
A systematic understanding of signaling by ErbB2 in cancer using phosphoproteomics. 2018 Biochemistry and cell biology = Biochimie et biologie cellulaire 96 Sidhanth C;Manasa P;Krishnapriya S;Sneha S;Bindhya S;Nagare RP;Garg M;Ganesan TS; 1208-6002 10.1139/bcb-2017-0020
Tumour angiogenesis-Origin of blood vessels. 2016 International Journal of Cancer 139 Krishna Priya S;Nagare RP;Sneha VS;Sidhanth C;Bindhya S;Manasa P;Ganesan TS; 1097-0215 10.1002/ijc.30067
Analysis of Human Stem Cell Transcription Factors. 2019 Cellular Reprogramming 21 Sneha S;Nagare RP;Manasa P;Vasudevan S;Shabna A;Ganesan TS; 2152-4998 10.1089/cell.2019.0005
The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary. 2020 Cellular Oncology (Dordrecht) 43 Sneha S;Nagare RP;Sidhanth C;Krishnapriya S;Garg M;Ramachandran B;Murhekar K;Sundersingh S;Ganesan TS; 2211-3436 10.1007/s13402-020-00504-w
Cancer Stem Cells - Are Surface Markers Alone Sufficient? 2017 Current Stem Cell Research and Therapy 12 Nagare RP;Sneha S;Priya SK;Ganesan TS; 2212-3946 10.2174/1574888x11666160607211436
LASP-1 interacts with ErbB2 in ovarian cancer cells. 2022 Biochemical Journal 479 Sidhanth C;Bindhya S;Shabna A;Krishnapriya S;Manasa P;Nagare RP;Joshua T;Sneha S;Murhekar K;Ganesan TS; 1470-8728 10.1042/BCJ20210173
ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo. 2020 Experimental Cell Research 392 Nagare RP;Sneha S;Krishnapriya S;Ramachandran B;Murhekar K;Vasudevan S;Shabna A;Ganesan TS; 1090-2422 10.1016/j.yexcr.2020.112009
Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours. 2020 Cancer Biomarkers : Section A Of Disease Markers 28 Nagare RP;Sneha S;Sidhanth C;Roopa S;Murhekar K;Shirley S;Swaminathan R;Sridevi V;Ganesan TS; 1875-8592 10.3233/CBM-201463
Analysis of hematopoietic stem cells using a composite approach. 2019 International Journal of Biochemistry and Cell Biology 109 Nagare RP;Sneha S;Ramesh S;Ganesan TS; 1878-5875 10.1016/j.biocel.2019.02.003
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer 2022 Journal of Medicinal Chemistry 65 Ali I M Ibrahim, Elisabet Batlle, Smarakan Sneha, Rafael Jiménez, Raquel Pequerul, Xavier Parés, Till Rüngeler, Vibhu Jha, Tiziano Tuccinardi, Maria Sadiq, Fiona Frame, Norman J Maitland, Jaume Farrés, Klaus Pors 10.1021/acs.jmedchem.1c01367
Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer. 2021 Scientific Reports 11 Presa D;Khurram SA;Zubir AZA;Smarakan S;Cooper PA;Morais GR;Sadiq M;Sutherland M;Loadman PM;McCaul J;Shnyder SD;Patterson LH;Pors K; 2045-2322 10.1038/s41598-021-98217-z
Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies. 2021 Biomedicines 9 Sneha S;Baker SC;Green A;Storr S;Aiyappa R;Martin S;Pors K; 2227-9059 10.3390/biomedicines9030290